• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛选用于1型人类免疫缺陷病毒诊断的抗p24重组、源自文库的抗体片段。

Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

作者信息

de Haard H J, Kazemier B, Koolen M J, Nijholt L J, Meloen R H, van Gemen B, Hoogenboom H R, Arends J W

机构信息

Biosciences Research Unit, Organon Teknika, Boxtel, Maastricht, The Netherlands.

出版信息

Clin Diagn Lab Immunol. 1998 Sep;5(5):636-44. doi: 10.1128/CDLI.5.5.636-644.1998.

DOI:10.1128/CDLI.5.5.636-644.1998
PMID:9729530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC95634/
Abstract

By application of combinatorial library technology, we generated the first recombinant antibody fragments directed against the major capsid protein p24 of human immunodeficiency virus type 1 (HIV-1). A library of single-chain Fv fragments (scFvs) was constructed by using the antibody variable-region (V) genes of B cells derived from the spleen of a viral lysate-immunized mouse. Antibodies were selected by panning or by enrichment with biotinylated antigen, yielding four different families of antibody fragments. The different types of scFvs were characterized by affinity measurements, by antigen recognition on Western blots, and by pepscan analysis. The epitope of one of the scFvs is located near the residues involved in CypA binding, thereby making it an attractive candidate for therapeutic applications. Comparison of the V gene sequence of this scFV with that of a previously described monoclonal antibody reactive against this immunodominant epitope revealed the usage of the identical combination of VH and Vkappa regions. Thus, this is one of the rare examples in which the original combination in a library-derived antibody fragment was retrieved. After appropriate affinity and format improvements, the best of our recombinant scFvs may form the basis for a sensitive p24 assay as a measure of viral load. In addition, anti-p24 scFvs could be expressed as intracellular antibodies (intrabodies) to aid in the treatment of HIV infections.

摘要

通过应用组合文库技术,我们生成了首个针对人类免疫缺陷病毒1型(HIV-1)主要衣壳蛋白p24的重组抗体片段。利用来自病毒裂解物免疫小鼠脾脏的B细胞抗体可变区(V)基因构建了单链Fv片段(scFvs)文库。通过淘选或用生物素化抗原富集来筛选抗体,得到了四个不同的抗体片段家族。通过亲和力测定、Western印迹上的抗原识别以及肽扫描分析对不同类型的scFvs进行了表征。其中一种scFvs的表位位于与亲环素A(CypA)结合相关的残基附近,因此使其成为治疗应用的有吸引力的候选物。将该scFV的V基因序列与先前描述的针对这一免疫显性表位的单克隆抗体的V基因序列进行比较,发现VH和Vκ区域的相同组合被使用。因此,这是从文库衍生的抗体片段中检索到原始组合的罕见例子之一。经过适当的亲和力和形式改进后,我们最好的重组scFvs可能构成一种灵敏的p24检测方法的基础,用于测量病毒载量。此外,抗p24 scFvs可表达为细胞内抗体(intrabodies)以辅助治疗HIV感染。

相似文献

1
Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.筛选用于1型人类免疫缺陷病毒诊断的抗p24重组、源自文库的抗体片段。
Clin Diagn Lab Immunol. 1998 Sep;5(5):636-44. doi: 10.1128/CDLI.5.5.636-644.1998.
2
Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody.通过抗p24(HIV-1)抗体的单点突变改变抗原结合特异性。
J Immunol. 2000 Oct 15;165(8):4505-14. doi: 10.4049/jimmunol.165.8.4505.
3
A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.在酵母中表达的肽库揭示了来自1型人类免疫缺陷病毒的新的主要表位。
FEMS Microbiol Immunol. 1991 Apr;3(2):99-107. doi: 10.1111/j.1574-6968.1991.tb04203.x.
4
Production of recombinant scFv against p24 of human immunodeficiency virus type 1 by phage display technology.利用噬菌体展示技术制备抗人免疫缺陷病毒1型p24的重组单链抗体片段
Monoclon Antib Immunodiagn Immunother. 2014 Feb;33(1):28-33. doi: 10.1089/mab.2013.0059.
5
In vitro affinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay.用于HIV诊断检测的抗P24抗体的体外亲和力成熟与表征
J Biochem. 2015 Dec;158(6):531-8. doi: 10.1093/jb/mvv070. Epub 2015 Jul 9.
6
Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies.用于核磁共振研究的人源HIV-1中和抗体447-52D的Fv片段的表达、纯化及同位素标记
Protein Expr Purif. 2003 Jun;29(2):291-303. doi: 10.1016/s1046-5928(03)00047-0.
7
Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells.从人宫颈B细胞开发抗HIV-1的功能性人单克隆单链可变片段抗体。
Hybrid Hybridomics. 2003 Apr;22(2):97-108. doi: 10.1089/153685903321948021.
8
Structural base of the interaction of a monoclonal antibody against p24 of HIV-1 with its peptide epitope.一种抗HIV-1 p24单克隆抗体与其肽表位相互作用的结构基础。
Mol Immunol. 1993 Sep;30(13):1213-21. doi: 10.1016/0161-5890(93)90140-7.
9
Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.针对人类免疫缺陷病毒1型Tat抗原的中和性人源单克隆抗体的产生与特性分析
J Virol. 2004 Apr;78(7):3792-6. doi: 10.1128/jvi.78.7.3792-3796.2004.
10
Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.源自免疫噬菌体展示文库的、对丙型肝炎病毒高变区1具有特异性的人重组单链抗体片段。
J Viral Hepat. 1999 Mar;6(2):115-24. doi: 10.1046/j.1365-2893.1999.00146.x.

引用本文的文献

1
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.一个 gp41 MPER 特异性的骆驼 VH 结构域需要一个疏水性的 CDR3 用于中和但不是用于抗原识别。
PLoS Pathog. 2013 Mar;9(3):e1003202. doi: 10.1371/journal.ppat.1003202. Epub 2013 Mar 7.
2
Chimeric peptide beacons: a direct polypeptide analog of DNA molecular beacons.嵌合肽信标:DNA分子信标的直接多肽类似物。
Chem Commun (Camb). 2007 Dec 14(46):4869-71. doi: 10.1039/b709776j.
3
Demystified...recombinant antibodies.揭秘……重组抗体。
J Clin Pathol. 2004 Sep;57(9):912-7. doi: 10.1136/jcp.2003.014407.
4
The production and application of single-chain antibody fragments.单链抗体片段的生产与应用。
Folia Microbiol (Praha). 2003;48(5):687-98. doi: 10.1007/BF02993480.
5
Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus.可识别梅迪-维斯纳病毒p25蛋白的重组单链Fv抗体。
Folia Microbiol (Praha). 2003;48(3):435-40. doi: 10.1007/BF02931380.

本文引用的文献

1
Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.用于筛选大量双特异性抗体片段的噬菌体双体文库。
Nat Biotechnol. 1996 Sep;14(9):1149-54. doi: 10.1038/nbt0996-1149.
2
p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents.使用易于获得的廉价试剂进行用于定量人类免疫缺陷病毒的p24抗原捕获测定。
Methods. 1997 Aug;12(4):288-93. doi: 10.1006/meth.1997.0481.
3
New protein engineering approaches to multivalent and bispecific antibody fragments.用于多价和双特异性抗体片段的新型蛋白质工程方法。
Immunotechnology. 1997 Jun;3(2):83-105. doi: 10.1016/s1380-2933(97)00067-5.
4
Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer.含有5个和10个残基连接子的抗神经氨酸酶抗体NC10的单链Fv片段形成二聚体,而含有零残基连接子的则形成三聚体。
Protein Eng. 1997 Apr;10(4):423-33. doi: 10.1093/protein/10.4.423.
5
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.使用热变性血浆的信号放大增强型HIV-1 p24抗原检测法对抗逆转录病毒疗法进行简单监测。
AIDS. 1997 May;11(6):F47-52. doi: 10.1097/00002030-199706000-00001.
6
Designing and optimizing library selection strategies for generating high-affinity antibodies.设计和优化用于产生高亲和力抗体的文库筛选策略。
Trends Biotechnol. 1997 Feb;15(2):62-70. doi: 10.1016/S0167-7799(97)84205-9.
7
Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity.与HIV-1 gag蛋白片段复合的亲环素A:对HIV-1感染活性的见解。
Structure. 1997 Jan 15;5(1):139-46. doi: 10.1016/s0969-2126(97)00172-x.
8
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.通过对抗体结合位点中心互补决定区进行分子进化分离出具有皮摩尔亲和力的抗c-erbB-2单链Fv。
J Mol Biol. 1996 Nov 8;263(4):551-67. doi: 10.1006/jmbi.1996.0598.
9
Crystal structure of dimeric HIV-1 capsid protein.二聚体HIV-1衣壳蛋白的晶体结构
Nat Struct Biol. 1996 Sep;3(9):763-70. doi: 10.1038/nsb0996-763.
10
Selection and evolution of high-affinity human anti-viral antibodies.
Trends Biotechnol. 1996 Jul;14(7):230-4. doi: 10.1016/0167-7799(96)10029-9.